Metropolitan Life Insurance CO Biomarin Pharmaceutical Inc Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

46 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$74.28 - $92.69 $270,230 - $337,206	-3,638 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$71.72 - $91.47 $260,917 - $332,767	3,638 New	3,638 $321,000
Q4 2021 Mar 30, 2023	SELL	$71.72 - $91.47 $9,682 - $12,348	-135 Reduced 3.58%	3,638 $321,000
Q4 2021 Feb 15, 2022	BUY	$71.72 - $91.47 $260,917 - $332,767	3,638 New	3,638 $321,000
Q3 2021 Jun 21, 2023	BUY	$74.77 - $85.47 $271,265 - $310,085	3,628 New	3,628 $280 Million
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $282,107 - $322,478	-3,773 Closed	0 $0
Q2 2021 Jun 21, 2023	BUY	$75.51 - $84.79 $284,899 - $319,912	3,773 New	3,773 $314,000
Q2 2021 Mar 30, 2023	SELL	$75.51 - $84.79 $614,349 - $689,851	-8,136 Reduced 68.32%	3,773 $314,000
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $283,993 - $318,895	3,761 Added 31341.67%	3,773 $315,000
Q1 2021 Jun 26, 2023	BUY	$74.73 - $90.69 $915,367 - $1.11 Million	12,249 New	12,249 $925 Million
Q1 2021 Mar 30, 2023	SELL	$74.73 - $90.69 $64,491 - $78,265	-863 Reduced 6.76%	11,909 $899,000
Q1 2021 May 14, 2021	SELL	$74.73 - $90.69 $953,554 - $1.16 Million	-12,760 Reduced 99.91%	12 $899,000
Q4 2020 Jun 22, 2023	BUY	$72.61 - $90.2 $927,374 - $1.15 Million	12,772 New	12,772 $1.12 Million
Q4 2020 Mar 30, 2023	SELL	$72.61 - $90.2 $18,370 - $22,820	-253 Reduced 1.94%	12,772 $1.12 Million
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $18,370 - $22,820	-253 Reduced 1.94%	12,772 $1.12 Million
Q3 2020 Jun 26, 2023	BUY	$71.87 - $131.03 $936,106 - $1.71 Million	13,025 New	13,025 $990,000
Q3 2020 Mar 30, 2023	SELL	$71.87 - $131.03 $23,932 - $43,632	-333 Reduced 2.49%	13,025 $990,000
Q3 2020 Nov 13, 2020	SELL	$71.87 - $131.03 $23,932 - $43,632	-333 Reduced 2.49%	13,025 $991,000
Q2 2020 Jun 26, 2023	BUY	$79.55 - $124.22 $1.06 Million - $1.66 Million	13,358 New	13,358 $1.65 Million
Q2 2020 Mar 30, 2023	BUY	$79.55 - $124.22 $65,390 - $102,108	822 Added 6.56%	13,358 $1.65 Million
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $65,390 - $102,108	822 Added 6.56%	13,358 $1.65 Million
Q1 2020 Jul 12, 2023	BUY	$71.37 - $96.85 $894,694 - $1.21 Million	12,536 New	12,536 $1.06 Million
Q1 2020 Mar 30, 2023	SELL	$71.37 - $96.85 $28,191 - $38,255	-395 Reduced 3.05%	12,536 $1.06 Million
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $28,191 - $38,255	-395 Reduced 3.05%	12,536 $1.06 Million
Q4 2019 Jul 12, 2023	BUY	$64.27 - $86.37 $831,075 - $1.12 Million	12,931 New	12,931 $1.09 Million
Q4 2019 Mar 30, 2023	SELL	$64.27 - $86.37 $15,489 - $20,815	-241 Reduced 1.83%	12,931 $1.09 Million
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $15,489 - $20,815	-241 Reduced 1.83%	12,931 $1.09 Million
Q3 2019 Jul 12, 2023	BUY	$67.4 - $85.11 $887,792 - $1.12 Million	13,172 New	13,172 $887,000
Q3 2019 Mar 30, 2023	BUY	$67.4 - $85.11 $10,649 - $13,447	158 Added 1.21%	13,172 $887,000
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $10,649 - $13,447	158 Added 1.21%	13,172 $888,000
Q2 2019 Jul 12, 2023	BUY	$80.35 - $93.9 $1.05 Million - $1.22 Million	13,014 New	13,014 $1.11 Million
Q2 2019 Mar 30, 2023	SELL	$80.35 - $93.9 $24,105 - $28,170	-300 Reduced 2.25%	13,014 $1.11 Million
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $24,105 - $28,170	-300 Reduced 2.25%	13,014 $1.12 Million
Q1 2019 Jul 13, 2023	BUY	$84.2 - $98.62 $1.12 Million - $1.31 Million	13,314 New	13,314 $1.18 Million
Q1 2019 Mar 30, 2023	BUY	$84.2 - $98.62 $1.12 Million - $1.31 Million	13,314 New	13,314 $1.18 Million
Q1 2019 May 16, 2019	BUY	$84.2 - $98.62 $135,056 - $158,186	1,604 Added 13.7%	13,314 $1.18 Million
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $158,548 - $185,701	-1,883 Reduced 13.85%	11,710 $812,000
Q4 2018 Jul 13, 2023	BUY	$80.14 - $106.07 $1.09 Million - $1.44 Million	13,593 New	13,593 $1.16 Million
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $3,526 - $4,667	-44 Reduced 0.32%	13,593 $1.16 Million
Q3 2018 Jul 13, 2023	BUY	$93.92 - $105.72 $1.28 Million - $1.44 Million	13,637 New	13,637 $1.32 Billion
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $25,546 - $28,755	-272 Reduced 1.96%	13,637 $1.32 Million
Q2 2018 Aug 15, 2018	BUY	$76.01 - $99.03 $65,444 - $85,264	861 Added 6.6%	13,909 $0
Q1 2018 May 15, 2018	BUY	$77.67 - $92.63 $233 - $277	3 Added 0.02%	13,048 $0
Q4 2017 Feb 15, 2018	SELL	$80.76 - $95.13 $9,852 - $11,605	-122 Reduced 0.93%	13,045 $1.16 Million
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $54,082 - $63,711	671 Added 5.37%	13,167 $1.23 Million
Q2 2017 Aug 14, 2017	BUY	N/A	12,496	12,496 $1.14 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account